Search - tctmd.com

Displaying 641 - 660 of 662

Sort: Relevancy | Date

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

Presentation TCT 2013

First Prize: Case Presentation: Transcatheter Valve Implantation in a Patient with Degenerated Tricuspid Bioprosthesis and Trivalvular Heart Disease

Presenter: Flavio Ribichini

November 01, 2013

News Conference News TCT 2013

TCT Honors Bernhard Meier with the Hartzler Master Clinical Operator Award

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

Presentation TCT 2013

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Anita Asgar

October 28, 2013

News Conference News TCT 2013

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

October 28, 2013

Presentation TCT 2013

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger, Bryce Einhorn, Vladimir Jelnin, Leandro Maranan, Gila Perk, itzhak kronzon, Howard Cohen, Carlos Ruiz

January 31, 2013

News Conference News TCT 2012

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

October 26, 2012

News Conference News TCT 2012

Centrifugal Pump Feasible Treatment for Refractory RV Failure

October 25, 2012

Presentation TCT 2012

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 23, 2012

Presentation TCT 2012

Concurrent Coronary Artery and Valvular Heart Disease 1: Hybrid PCI with Surgical Valves

Presenter: Isaac George

October 23, 2012

Presentation TCT 2012

Concurrent Coronary Artery and Valvular Heart Disease 2: Hybrid PCI with Transcatheter Valves

Presenter: Jean-Michel Paradis

October 23, 2012

News Conference News TCT 2012

Registries Show Low Complication Rates With New Heart Valves

October 23, 2012

News Conference News TCT 2012

Registries Demonstrate Positive Long-Term Outcomes with TAVR

October 23, 2012

Presentation TCT 2012

The “Heart Team” Management Approach in Valvular Heart Disease: Components and Value Proposition - A Sustainable Model for the Future?

Presenter: A. Pieter Kappetein

October 22, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

News Conference News TCT 2012

PARTNER Analyses Provide Important Insights into TAVR

October 22, 2012

Presentation TCT 2012

The Effects of Pre-existing Significant Coronary Artery Disease Defined by QCA Analysis Upon Outcome After Transcatheter Aortic Valve Implantation Using the Edwards Bioprosthesis

Presenter: Muhammed Z. Khawaja, Kaleab Asress, Hari Haran, Imad Nadra, Karen Wilson, Kirsty MacGillivray, Jane Hancock, Christopher Young, Vinayak Bapat, Simon Redwood, Martyn Thomas

January 03, 2012

Advertisement

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

First Prize: Case Presentation: Transcatheter Valve Implantation in a Patient with Degenerated Tricuspid Bioprosthesis and Trivalvular Heart Disease

TCT Honors Bernhard Meier with the Hartzler Master Clinical Operator Award

Innovation in Intervention: Perspectives from Industry

Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

Centrifugal Pump Feasible Treatment for Refractory RV Failure

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Concurrent Coronary Artery and Valvular Heart Disease 1: Hybrid PCI with Surgical Valves

Concurrent Coronary Artery and Valvular Heart Disease 2: Hybrid PCI with Transcatheter Valves

Registries Show Low Complication Rates With New Heart Valves

Registries Demonstrate Positive Long-Term Outcomes with TAVR

The “Heart Team” Management Approach in Valvular Heart Disease: Components and Value Proposition - A Sustainable Model for the Future?

Review of TAVR Use Offers Significant Advances, Positive Outcomes

PARTNER Analyses Provide Important Insights into TAVR

The Effects of Pre-existing Significant Coronary Artery Disease Defined by QCA Analysis Upon Outcome After Transcatheter Aortic Valve Implantation Using the Edwards Bioprosthesis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content